{
    "2019-04-11": [
        [
            {
                "time": "",
                "original_text": "券商评级:三大股指全线挫九股迎掘金良机",
                "features": {
                    "keywords": [
                        "券商评级",
                        "三大股指",
                        "全线挫",
                        "掘金良机"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "收评：沪股通净流出14.73亿深股通净流出22.15亿",
                "features": {
                    "keywords": [
                        "沪股通",
                        "深股通",
                        "净流出"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "本月26日",
                "original_text": "港股异动 | 上海医药AH股涨幅均超4% 本月26日发一季度业绩",
                "features": {
                    "keywords": [
                        "港股异动",
                        "上海医药",
                        "AH股",
                        "涨幅",
                        "一季度业绩"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药:2019年股票期权激励计划点评:医药国企改革新标杆,激励助力盈利改善和创新升级",
                "features": {
                    "keywords": [
                        "上海医药",
                        "股票期权",
                        "激励计划",
                        "国企改革",
                        "盈利改善",
                        "创新升级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}